Medicine
Perampanel 0.5 mg/mL oral suspension
Perampanel 0.5 mg/mL oral suspension is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Oral Suspension: Do not store above 30°C (86°F).
Key facts
- Active ingredient (INN)
- Perampanel
- Brand
- Sold under the generic name
- Strength
- 0.5 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 340 mL, 1 bottle
- Manufacturers
- Novadoz PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndia
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Oral Suspension: Do not store above 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIII
- ATC code
- N03AX22 Perampanel
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 July 2025
- Identifiers
- RxCUI 1790122DailyMed set ID 4d8be129-f3cb-49ad-ae5a-a74a50dff689, 3c72a5f7-bb22-4c48-942a-543ca84ed5a9NDC 72205-071, 51672-4256Application ANDA218152, ANDA219052
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 340 mL in 1 bottle | 72205-071-79 | Novadoz PharmaceuticalsIndia | 15 December 2025 |
| 1 bottle in 1 carton / 340 mL in 1 bottle | 51672-4256-9 | Sun Pharmaceutical IndustriesIndia | 16 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Perampanel 0.5 mg/mL oral suspension.
Other strengths and forms of Perampanel
Clinical summary
Perampanel is a noncompetitive AMPA glutamate receptor antagonist indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older, among other approved uses. MedsAcross supplies Perampanel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PerampanelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Fycompa prescribing information (Catalyst Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Fycompa: European public assessment report (EPAR) · European Medicines Agency
Need Perampanel 0.5 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.